Pipeline Previews

By No Comments
New Recommendations for Pediatric AcneAcne is one of the most common skin conditions in children and adolescents, and there are increasing amounts of acne seen in younger age groups. In…
Read More

Clinical Trial Review

By No Comments
BASAL CELL CARCINOMAA Randomized, Double-blinded, Regimen-controlled, Phase II, Multicenter Study to Assess the Efficacy and Safety of Two Different Vismodegib Regimens in Patients With Multiple Basal Cell Carcinomas Sponsored by…
Read More

IncobotulinumtoxinA in Esthetics

By No Comments
INTRODUCTIONCharacteristics of IncobotulinumtoxinA IncobotulinumtoxinA (Xeomin®/Xeomeen®/Bocouture®/XEOMIN Cosmeticâ„¢; Merz Pharmaceuticals GmbH, Germany), along with onabotulinumtoxinA (BOTOX®/BOTOX® Cosmetic/Vistabel®; Allergan, Irvine, CA, USA) and abobotulinumtoxinA (Dysport®; Ipsen Ltd, Slough, Berkshire, UK / Azzalure®; Galderma…
Read More

Onchomycosis: An Overview

By No Comments
INTRODUCTIONOnychomycosis is a fungal infection of the nail unit, more common in toenails than in fingernails,1 and caused by a variety of fungi including dermatophytes, nondermatophyte molds, and Candida.2,3 There…
Read More

The Integration of Physiologically-Targeted Skin Care in the Management of Atopic Dermatitis: Focus on the Use of a Cleanser and Moisturizer System Incorporating a Ceramide Precursor, Filaggrin Degradation Products, and Specific “Skin-Barrier–Friendly” Excipients

By No Comments
INTRODUCTION Atopic dermatitis (AD) is one of the most common dermatologic disorders encountered in both pediatric and general dermatologic practices in the United States and globally, especially in well-developed countries…
Read More